'Sunitinib withdrawal phenomenon' or spontaneous regression in renal cell cancer.
Rothermundt
C A
CA
Omlin
A
A
Gillessen
S
S
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy* / Q000556:secondary; D018450:Disease Progression; D005260:Female; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000188:drug therapy* / Q000556:secondary; D008875:Middle Aged; D011758:Pyrroles / Q000627:therapeutic use*; D012074:Remission Induction; D012075:Remission, Spontaneous; D000077210:Sunitinib
D000970:Antineoplastic Agents; D007211:Indoles; D011758:Pyrroles; D000077210:Sunitinib